PeptideAA Water
0.9% Benzyl Alcohol Preserved Water. Sterile. 10ml vial.

GLP-1 / GIP / Glucagon triple receptor agonist. Lyophilized.
In Stock
Retatrutide is a synthetic peptide that acts as a triple agonist of the GLP-1, GIP, and glucagon receptors.
The compound is characterised in preclinical metabolic-research literature as a reference triple-incretin agonist.
Lyophilized under inert atmosphere. Reconstitute with sterile bacteriostatic water; store reconstituted samples refrigerated. For laboratory and research use only. Not for human or veterinary use.
Every batch of Retatrutide is independently tested by a third-party laboratory. Certificates of Analysis include HPLC purity testing, mass spectrometry confirmation, and sterility verification.
Contact us at info@spartalabs.net to request the COA for this product.
Orders are processed within 1–2 business days. Standard shipping typically takes 3–5 business days within the continental United States.
All products are shipped in temperature-controlled, discreet packaging to ensure product integrity.
Retatrutide is a synthetic peptide that acts as a triple agonist of the GLP-1, GIP, and glucagon receptors.
The compound is characterised in preclinical metabolic-research literature as a reference triple-incretin agonist.
Lyophilized under inert atmosphere. Reconstitute with sterile bacteriostatic water; store reconstituted samples refrigerated. For laboratory and research use only. Not for human or veterinary use.
Peptide0.9% Benzyl Alcohol Preserved Water. Sterile. 10ml vial.
PeptideBacteriostatic Water for Research. Sterile. 10ml vial.
PeptideTetra-substituted GHRH analogue with Drug Affinity Complex. Lyophilized.
PeptideCo-lyophilized 10 mg BPC-157 / 10 mg TB-500. ≥ 99% purity.
PeptideFour-peptide blend: GHK-Cu, TB-500, BPC-157, KPV. 80 mg total. Lyophilized.
PeptideCo-lyophilized 5 mg BPC-157 / 5 mg TB-500. ≥ 99% purity.
PeptideSynthetic hexapeptide ghrelin-receptor agonist. Lyophilized.
PeptideSynthetic tetrapeptide (Ala-Glu-Asp-Gly). Lyophilized.
PeptideSynthetic pentadecapeptide. Lyophilized. ≥ 99% purity.
PeptideLong-acting amylin analogue. Lyophilized. ≥ 99% purity.
PeptideTetra-substituted GHRH (1-29) analogue, no DAC. Lyophilized. ≥ 99% purity.
PeptideModified C-terminal fragment (Tyr-hGH 177-191) of human growth hormone. Lyophilized.
No reviews yet. Be the first verified buyer to share your experience from your account → orders page after your shipment arrives.
Reviews are open to verified buyers from your account → orders page. Every submission is moderated for compliance — we filter human-use and medical claims evenhandedly across positive and negative reviews. See our review moderation policy for the exact rules and 1–2 business-day review window.
How SpartaLabs sources, tests, and verifies retatrutide for research applications. Educational reference.
A research-library summary of published peer-reviewed studies on retatrutide (LY3437943) across preclinical characterization, phase 1, phase 2, and phase 3 clinical trial settings. Educational reference.
A research-library overview of retatrutide (LY3437943) — chemistry, pharmacological classification as a triple receptor agonist, and regulatory status as an investigational compound. Educational reference.
A research-library summary of the reported receptor pharmacology and signaling mechanisms of retatrutide (LY3437943), an investigational triple GIP, GLP-1, and glucagon receptor agonist. Educational reference.
A research-library account of retatrutide's (LY3437943) discovery period, scientific lineage across three receptor systems, clinical development milestones, and current investigational status. Educational reference.